Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2009

Dec 23, 2009

34519_dirs_2009-12-23_305029fb-8164-4c71-a902-160893e4a55e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-12-22

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-12-22 Common Stock, par value $0.10 per share P 1000 $3.78 Acquired 456081 Direct
2009-12-23 Common Stock, par value $0.10 per share P 200 $3.8045 Acquired 456281 Direct
2009-12-23 Common Stock, par value $0.10 per share P 200 $3.80 Acquired 456481 Direct
2009-12-23 Common Stock, par value $0.10 per share P 200 $3.81 Acquired 456681 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.

F2: This figure includes 189,737 of common stock, held by Arterio, Inc., a company owned solely by Jonathan Rothschild.